(Q77766244)
Statements
Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty. Results of the Glycoprotein Receptor Antagonist Patency Evaluation (GRAPE) pilot study (English)
L F van den Merkhof
H Olsson
L Grip
G Veen
F W Bär
M J van den Brand
M L Simoons